Leaf Rebecca K, Ricci Andrea, Tran Benny, Corradini Elena, Pietrangelo Antonello, Mancini Camilla, Garuti Cinzia, Saltini Dario, Schepis Filippo, Kubisch Ilja, Wohmann Nils, Stölzel Ulrich, Jiang Paul Y, Jang Samuel, Bensaber Narmene, Rebeiz Lina, Wang Chenqing, Buzney Elizabeth, Trinidad John, Anderson Karl E, Wahlin Staffan, Ventura Paolo, Dickey Amy K
Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.
Br J Haematol. 2025 Jun 10. doi: 10.1111/bjh.20197.
Erythropoietic protoporphyria (EPP) is a disorder of haem biosynthesis characterized by a reduction in ferrochelatase and subsequent accumulation of protoporphyrin IX. Haematological aberrations in EPP have been described, though they remain poorly understood. We present a detailed analysis of haematological parameters in EPP, drawing upon data from four large cohorts in the United States and Europe. We show an association between protoporphyrin levels and both platelet count and spleen size, and in a case-control analysis, we describe significant differences between haematological indices in EPP patients versus controls.
红细胞生成性原卟啉病(EPP)是一种血红素生物合成紊乱疾病,其特征是亚铁螯合酶减少以及原卟啉IX随后积累。EPP中的血液学异常已有描述,但其仍知之甚少。我们利用来自美国和欧洲四个大型队列的数据,对EPP中的血液学参数进行了详细分析。我们发现原卟啉水平与血小板计数和脾脏大小之间存在关联,并且在病例对照分析中,我们描述了EPP患者与对照组血液学指标的显著差异。